{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:34:00Z","timestamp":1759336440646},"reference-count":18,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T00:00:00Z","timestamp":1377820800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0072876","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T21:26:18Z","timestamp":1377897978000},"page":"e72876","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Concentrations of the Stress Hormone Copeptin Increase upon Hypoglycaemia in Patients with Type 1 Diabetes Dependent of Hypoglycaemia Awareness"],"prefix":"10.1371","volume":"8","clinical-trial-number":[{"clinical-trial-number":"nct00515801","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Eleonora","family":"Seelig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Bilz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Meienberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam","family":"Christ-Crain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,8,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.2337\/db08-1084","article-title":"The barrier of hypoglycemia in diabetes","volume":"57","author":"PE Cryer","year":"2008","journal-title":"Diabetes"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(77)90610-9","article-title":"Plasma-arginine-vasopressin response to insulin-induced hypoglycaemia","volume":"2","author":"PH Baylis","year":"1977","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1749-6632.2010.05820.x","article-title":"Neuroendocrine responses to hypoglycemia","volume":"1212","author":"N Tesfaye","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/jcem-68-3-688","article-title":"Arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in type 1 (insulin-dependent) diabetes","volume":"68","author":"BM Fisher","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1006\/frne.1993.1004","article-title":"Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age","volume":"14","author":"FA Antoni","year":"1993","journal-title":"Front Neuroendocrinol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2362.2007.01762.x","article-title":"Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections","volume":"37","author":"B Muller","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/ana.21783","article-title":"Copeptin: a novel, independent prognostic marker in patients with ischemic stroke","volume":"66","author":"M Katan","year":"2009","journal-title":"Ann Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/SHK.0b013e318033e5da","article-title":"Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock","volume":"28","author":"NG Morgenthaler","year":"2007","journal-title":"Shock"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jacc.2009.01.076","article-title":"Incremental value of copeptin for rapid rule out of acute myocardial infarction","volume":"54","author":"T Reichlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/jc.2006-2046","article-title":"Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay","volume":"92","author":"M Katan","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin","volume":"52","author":"NG Morgenthaler","year":"2006","journal-title":"Clin Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0002-9343(99)80077-1","article-title":"Blood glucose estimation and symptoms during hyperglycemia and hypoglycemia in patients with insulin-dependent diabetes mellitus","volume":"98","author":"K Weinger","year":"1995","journal-title":"Am J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0024-3205(98)00027-7","article-title":"Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression","volume":"62","author":"LV Scott","year":"1998","journal-title":"Life Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1464-5491.1989.tb02106.x","article-title":"Vasopressin secretion during insulin-induced hypoglycaemia: exaggerated responses in people with type 1 diabetes","volume":"6","author":"CJ Thompson","year":"1989","journal-title":"Diabet Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1172\/JCI107423","article-title":"Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma","volume":"52","author":"GL Robertson","year":"1973","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"I129","DOI":"10.1161\/01.HYP.5.2_Pt_2.I129","article-title":"Plasma and platelet vasopressin in essential hypertension and congestive heart failure","volume":"5","author":"JJ Preibisz","year":"1983","journal-title":"Hypertension"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/j.peptides.2005.04.019","article-title":"Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients","volume":"26","author":"J Struck","year":"2005","journal-title":"Peptides"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1056\/NEJMra031354","article-title":"Diverse causes of hypoglycemia-associated autonomic failure in diabetes","volume":"350","author":"PE Cryer","year":"2004","journal-title":"N Engl J Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0072876","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T04:03:38Z","timestamp":1540526618000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0072876"}},"subtitle":[],"editor":[{"given":"Jianping","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,30]]},"references-count":18,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0072876","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,30]]}}}